Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2021 Feb 4;11(2):e303. doi: 10.1002/ctm2.303

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

The serum LPC (18:0) level for discriminating non‐diabetic pneumonia patients and pneumonia patients with T2DM. (A) Decreasing trend of serum LPC (18:0) level in pneumonia patients with T2DM in relation to non‐diabetic pneumonia patients. (B) Relative serum LPC (18:0) level in pneumonia patients with T2DM based on SMART‐COP score. (C) Positive correlation between serum LPC (18:0) level and serum albumin level in pneumonia patients with T2DM. (D) Negative correlation between serum LPC (18:0) level and neutrophil‐to‐lymphocyte ratio in pneumonia patients with T2DM. ^*p < 0.05 represents significant difference for the group compared with the healthy control group

Abbreviation: NLR, neutrophil‐to‐lymphocyte ratio.